Skip to main content
OpenTrials
Completed

NCT Number: NCT00090181

Study of MK0663 in Patients With Chronic Low Back Pain (0663-806)(COMPLETED)

The purpose of this study is to evaluate the efficacy of MK0663 for the treatment of chronic low back pain and to investigate the overall safety and tolerability over four weeks of treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Low Back Pain

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male and female patients 18 years of age or older, who have Chronic Low Back Pain after the discontinuation of their previous medication for their condition.
  • Patients should have at least 3 months of Low Back Pain.

Treatment and study plan

MK0663, etoricoxib / Duration of Treatment: 4 weeks

Drug

Comparator: diclofenac / Duration of Treatment: 4 weeks

Drug

Primary outcomes

  1. Lower back pain intensity

  2. Safety and tolerability

Secondary outcomes

  1. Disability questionnaire

  2. Patient global assessment of response to therapy

Sponsors and collaborators

Lead sponsor

Organon and Co

Industry

Registry information

Official study title

A Double-Blind, Parallel-group, 4-Week Trial to Assess the Efficacy and Safety of Etoricoxib 60 mg and Diclofenac 150 mg in Patients With Chronic Low Back Pain

Important dates

Study start
2004
Primary completion
2005
Study completion
2005
First posted
Aug 27, 2004
Registry last updated
Feb 15, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.